At present, surgery is still the most effective treatment for early-stage lung cancer patients to obtain long-term survival. Since the surgical risk for senior early-stage lung cancer patients is much higher than that for middle-aged and elderly patients, many senior early-stage lung cancer patients and their family members have a lot of concerns about open-heart lung resection surgery, and always feel that the surgical risk is too great and refuse the surgery because they don’t have any confidence. In fact, China has introduced clinical diagnosis and treatment standard and clinical pathway of lung cancer thoracic surgery for lung cancer treatment, and thoracic surgeons need to conduct a comprehensive physical examination and assess the overall condition of the patient before surgery for senior lung cancer patients, and observe whether there are any lesions or decompensation of important organs according to various examination and laboratory results, especially the cardiopulmonary function and liver and kidney function of senior lung cancer patients. The patient’s cardiopulmonary function, liver and kidney function are particularly important for the elderly lung cancer patients. With the maturity of modern surgical technology and the popularity of minimally invasive lumpectomy, there is now a consensus in the thoracic surgery field in China that age is no longer a contraindication to lung cancer surgery. In addition, if senior lung cancer patients are combined with severe hypertension, acute myocardial infarction or severe diabetes mellitus, they are not suitable for immediate surgery, and they can be treated actively in related disciplines in general hospitals first, and then scheduled for elective surgery after the combined diseases are controlled and stabilized. In recent years, with the popular application of minimally invasive surgical techniques and lumpectomy technology, thoracoscopic lobectomy has been very maturely and routinely applied in lung cancer surgery, and its surgical treatment effect is consistent with the previous traditional open-heart surgery. This minimally invasive surgery is mainly applicable to early stage lung cancer patients, such as stage I and II peripheral lung cancer patients, and is especially suitable for elderly early stage lung cancer patients who cannot tolerate traditional open-heart surgery. Since minimally invasive thoracic surgery uses three or two small incisions of about 3 centimeters instead of the large incisions of tens of centimeters in the traditional open chest, and it no longer routinely cuts 1-2 ribs and various layers of muscle tissues in the chest wall, the degree of surgical trauma is greatly reduced, so that senior early-stage lung cancer patients can obtain faster and smoother postoperative recovery. At present, thoracoscopic radical lung cancer surgery in large lung cancer centers or tertiary hospitals in China, including the thoracic surgery department and lung cancer center of Xuanwu Hospital, has become routine for early-stage lung cancer, accounting for more than 90% of early-stage lung cancer surgeries, and the hospital stay after surgery is 5-7 days, while traditional open-heart surgery requires at least 2 weeks of hospital stay before discharge. With the increasing aging process of China’s population and the popular application of chest CT in health checkups and lung cancer screening, more and more elderly early-stage lung cancer patients will be able to obtain diagnosis at an early stage, and minimally invasive surgical techniques can enable these elderly patients to obtain safe radical treatment.